Identification of autoantibodies targeting podocyte-specific proteins, including phospholipase A2 receptor (PLA2R) in patients with MN and nephrin in patients with MCD and FSGS, support the central role of podocytes in PNS pathogenesis.9 The gene discussed is NPHS1; the disease is paraneoplastic neurologic syndrome.